StockData
CVS HEALTH Corp logo

CVS HEALTH Corp

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)

Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%

Cvs Health Allowance for Credit Losses on Accounts Receivable by Quarter

Allowance for Credit Losses on Accounts Receivable ($M)

QuarterlyAnnual

Cvs Health Allowance for Credit Losses on Accounts Receivable: $169M in Q2 2026, down 54.8% from a year earlier.

Latest, Q2 2026
169
Period ended Jun 30, 2026
Change on a year earlier
-54.8%
374 in Q2 2025
History
30 quarters
Since Q4 2016
Sources
2
Documents cited below

Where the Q2 2026 figure comes from

Source: CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAllowance for Credit Losses on Accounts Receivable ($M)Year on yearSource
Q2 2026Jun 30, 2026169-54.8%CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q1 2026Mar 31, 2026200-49.0%CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q4 2025Dec 31, 2025182-55.3%CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q3 2025Sep 30, 2025178-48.6%CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q2 2025Jun 30, 2025374+5.4%CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q1 2025Mar 31, 2025392-2.5%CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q4 2024Dec 31, 2024407+18.7%CVS SEC 10-K (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q3 2024Sep 30, 2024346-3.1%CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q2 2024Jun 30, 2024355+13.4%CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q1 2024Mar 31, 2024402+24.1%CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q4 2023Dec 31, 2023343+3.0%CVS SEC 10-K (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q3 2023Sep 30, 2023357+3.8%CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q2 2023Jun 30, 2023313-7.9%CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q1 2023Mar 31, 20233240.0%CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q4 2022Dec 31, 2022333-1.8%CVS SEC 10-K (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Q3 2022Sep 30, 2022344-5.5%CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗

Cite this data

StockData. (2026). Cvs Health Allowance for Credit Losses on Accounts Receivable ($M), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/ar-allowance

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.